Benzinga Financial News & Data vs 리타민(RETAMIN) - 건강한 투자 습관

Benzinga Financial News & Data

Accretive Capital llc
App Store
$60.6K/mo
~$727.1K/yr · 598K installs
VS

리타민(RETAMIN) - 건강한 투자 습관

FnGuide
Google Play
$12.4K/mo
~$148.7K/yr · 60K installs
Revenue winner Benzinga Financial News & Data wins +389% vs other
Installs winner Benzinga Financial News & Data wins +898% vs other
MAU winner Benzinga Financial News & Data wins +952% vs other
Rating winner Benzinga Financial News & Data wins +470% vs other

Why Benzinga Financial News & Data is winning

Top 4 reasons - backed by the public App Store / Play Store numbers.

  1. Benzinga Financial News & Data earns roughly 5× more per month than 리타민(RETAMIN) - 건강한 투자 습관 - $60.6K vs $12.4K.
  2. Premium pricing. Benzinga Financial News & Data charges $46.99/mo vs 리타민(RETAMIN) - 건강한 투자 습관's $21.26/mo - higher ARPU per converted user.
  3. Bigger install base. Benzinga Financial News & Data has ~598K lifetime installs vs 리타민(RETAMIN) - 건강한 투자 습관's ~60K - 10.0× the funnel top.
  4. More monetization surfaces. Benzinga Financial News & Data runs 10 IAP tiers vs 0 - more chances to convert users at the right price.

→ Find more apps with this revenue gap · Full Benzinga Financial News & Data report

Side-by-side metrics

Bars scale to whichever app is bigger on that row. Green = winner.

Benzinga Financial News & Data
vs
리타민(RETAMIN) - 건강한 투자 습관
Monthly revenue (est.)?
$60.6K
◀
$12.4K
Annual revenue (est.)
$727.1K
◀
$148.7K
Lifetime installs (est.)
598K
◀
60K
Monthly active users (est.)?
256K
◀
24K
App Store rating
4.70★
◀
-
Total ratings
7K
◀
0
US grossing rank
-
=
-
Cheapest monthly sub
$46.99
◀
$21.26
IAP tiers detected
10 tiers
◀
0 tiers

Benzinga Financial News & Data

Accretive Capital llc
App Store
Category
Finance
Price
Free
Released
Aug 22, 2013
Last updated
Mar 6, 2026
File size
69.2 MB
Content rating
4+
Version
3.6.1
Languages
English
View full Benzinga Financial News & Data report →

리타민(RETAMIN) - 건강한 투자 습관

FnGuide
Google Play
Category
Finance
Price
Free
Released
Jul 12, 2021
Last updated
May 4, 2026
File size
-
Content rating
Everyone
Version
3.1.2
Languages
-
View full 리타민(RETAMIN) - 건강한 투자 습관 report →

Benzinga Financial News & Data trajectory

JunJulAugSepOctNovDecJanFebMarAprMay

리타민(RETAMIN) - 건강한 투자 습관 trajectory

JunJulAugSepOctNovDecJanFebMarAprMay

Related app pages

Benzinga Financial News & Data App Store page →리타민(RETAMIN) - 건강한 투자 습관 Play Store page →

Related comparisons

Benzinga Financial News Data iOS vs Binance Us Buy Btc Crypto iOSBenzinga Financial News Data iOS vs Binance Buy Bitcoin Crypto AndroidBenzinga Financial News Data iOS vs Monzo Mobile Banking AndroidBenzinga Financial News Data iOS vs Google Wallet AndroidBenzinga Financial News Data iOS vs Paypal Pay Send Save AndroidBenzinga Financial News Data iOS vs Wise International Transfers Android

Compare another pair

FAQ

Which makes more money, Benzinga Financial News & Data or 리타민(RETAMIN) - 건강한 투자 습관? v
Benzinga Financial News & Data earns about $60.6K per month, while 리타민(RETAMIN) - 건강한 투자 습관 earns about $12.4K. That is a 4.9× revenue gap (~$48.2K more per month for Benzinga Financial News & Data). Annual revenue: Benzinga Financial News & Data ≈ $727.1K/year, 리타민(RETAMIN) - 건강한 투자 습관 ≈ $148.7K/year. Estimates are derived from public App Store / Google Play signals - grossing rank, scraped IAP tiers, ratings and category benchmarks.
Which has more downloads, Benzinga Financial News & Data or 리타민(RETAMIN) - 건강한 투자 습관? v
Benzinga Financial News & Data leads with about 598K estimated downloads vs 60K for 리타민(RETAMIN) - 건강한 투자 습관 - a 10.0× gap. Benzinga Financial News & Data's App Store downloads are estimated from 7K ratings × the standard 1:75 ratio. 리타민(RETAMIN) - 건강한 투자 습관 reports 50,000+ installs on Google Play.
Are Benzinga Financial News & Data and 리타민(RETAMIN) - 건강한 투자 습관 in the same App Store category on each store and competing for the same money? v
Yes - both apps sit in the Finance category, which means they compete directly for the same paying users and category-level wallet share. Direct competitors, head-to-head.
What in-app purchases and subscription pricing do Benzinga Financial News & Data and 리타민(RETAMIN) - 건강한 투자 습관 offer? v
Benzinga Financial News & Data: IAP range 10 tiers detected. 리타민(RETAMIN) - 건강한 투자 습관: IAP range $7.29 - $61.99 per item. Benzinga Financial News & Data runs a "Subscription (~$7.33/mo)" monetization model; 리타민(RETAMIN) - 건강한 투자 습관 runs "Subscription (~$21.26/mo)". Scraped tier prices and detected subscription pricing drive the bulk of the per-app revenue estimate above.
Which has better ratings, Benzinga Financial News & Data or 리타민(RETAMIN) - 건강한 투자 습관? v
Benzinga Financial News & Data edges ahead with a higher overall score (gap of 4.7 stars). Rating volume: Benzinga Financial News & Data 7K ratings, 리타민(RETAMIN) - 건강한 투자 습관 0 ratings. Higher rating volume = stronger ASO signal even when star averages are close.
How accurate are these Benzinga Financial News & Data vs 리타민(RETAMIN) - 건강한 투자 습관 revenue estimates? v
Directional - typically within 2-3× of actual money earned for popular apps. The $60.6K for Benzinga Financial News & Data and $12.4K for 리타민(RETAMIN) - 건강한 투자 습관 are derived from App Store grossing rank / Google Play install ranges, scraped IAP tiers, ratings volume and category benchmarks (Finance) - net of the 15-30% Apple/Google store cut. Real revenue depends on country mix, retention, refunds and ad fill rate, none of which Apple or Google publish.
How do I compare Benzinga Financial News & Data or 리타민(RETAMIN) - 건강한 투자 습관 to a different App Store app? v
Use the search box at the bottom of this page or paste any two App Store or Google Play links into the homepage tool. We auto-generate a permanent comparison URL with revenue, downloads, IAP tiers, subscription pricing and grossing rank for both apps.